THE ROLE OF ETHICS COMMITTEES IN ITALY: SCOPE OF APPLICATION AND IMPACT OF EUROPEAN REGULATION 536/ 14

被引：0
|
作者：
Poluzzi, Elisabetta [1 ]
Iacono, Corrado [2 ]
机构：
[1] Univ Bologna, Alma Mater Studiorum, Dipartimento Sci Med Chirurg, Bologna, Italy
[2] Azienda Unita Sanitaria Locale Bologna, Unita Operat Governo Clin Ric Formazione Ssistem, Bologna, Italy
来源：
BIOLAW JOURNAL-RIVISTA DI BIODIRITTO | 2022年 / 04期
关键词：
Ethics Committee; clinical trials; medicinal products; patient safety; data protection;
D O I：
暂无
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
Ethics committee activity is strictly embedded in the development and implementation of clinical research: from the most regulated clinical trials on medicines, to retrospective observational studies without medicines, with lower clinical risk for involved subjects, but with potential risks for data protection and quality of evidence dumped in the scientific literature. The application of the 536/14 regulation aims to accelerate authorisation of clinical trials on medicines, by requiring the assessment by only one Ethics Committee per Country and tight deadlines. Strict monitoring of these studies during their implementation is needed, with the aim to verify the actual compliance with the main principles of clinical research.
引用
收藏
页码：237 / 250
页数：14
相关论文
共 26 条
123